Nucleometric study of anisonucleosis, diabetes and oxidative damage in liver biopsies of orthotopic liver transplant recipients with chronic hepatitis C virus infection

Pathology and Oncology Research

Volumn 17, Issue 2, 2011, Pages 191-199

  Guzman, Grace ^a   Chennuri, Rohini ^a   Voros, Andras ^a,b   Boumendjel, Redouane ^a   Locante, Alberto ^a   Patel, Roshan ^a   Valyi Nagy, Tibor ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

8 Hydroxy 2 deoxyguanosine (8 OHDG) immunomarker; Diabetes; Hepatitis C virus (HCV); Hepatocyte anisonucleosis; Image analysis; Nucleometry; Oxidative damage

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CYCLOSPORIN; TACROLIMUS;

ADOLESCENT; ADULT; AGE; AGED; ANISONUCLEOSIS; ARTICLE; BODY MASS; CADAVER DONOR; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; DISEASE MARKER; FATTY LIVER; FEMALE; GENDER; GRAFT RECIPIENT; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER CELL NUCLEUS; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MICROSCOPY; NUCLEAR SIZE; OXIDATION; POSTOPERATIVE PERIOD; RACE; RECURRENT INFECTION;

ADOLESCENT; ADULT; AGED; BIOPSY; CELL NUCLEUS; DEOXYGUANOSINE; DIABETES MELLITUS; FEMALE; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; YOUNG ADULT;

EID: 80051663374     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-010-9296-0     Document Type: Article

References (32)

1. Crawford JM (2004) The liver and biliary tree. Kumar VFN, Abbas A (eds). Philadelphia, WB Saunders, pp 877-937
2. Henmi A, Uchida T, Shikata T (1985) Karyometric analysis of liver cell dysplasia and hepatocellular carcinoma. Evidence against precancerous nature of liver cell dysplasia. Cancer 55:2594-2599 (Pubitemid 15092144)
3. Zeppa P, Zabatta A, Fulciniti F, Vetrani A, Di Benedetto G, De Rosa G, Palombini L (1988) The role of morphometry in the cytology of well-differentiated hepatocarcinoma and cirrhosis with atypia. Anal Quant Cytol Histol 10:343-348
4. Kuo SH, Lai MY, Liu YR, Lee YT, Chen DS, Lee CS, Hsu HC (1994) Nuclear area and DNA content in tumor and nontumor portions of hepatocellular carcinoma. Anal Quant Cytol Histol 16:153-158
5. Koutselini H, Lazaris AC, Kavantzas N, Kiritsi T, Davaris PS (2000) Significance of nuclear morphometry as a diagnostic tool in fine-needle aspirates of the liver. Eur J Gastroenterol Hepatol 12:913-921 (Pubitemid 30663904)
6. Wood LJ, Mundo F, Searle J, Powell LW (1985) Sulindac hepatotoxicity: effects of acute and chronic exposure. Aust NZ J Med 15:397-401 (Pubitemid 16215372)
7. Chadee K, Meerovitch E (1984) The pathogenesis of experimentally induced amebic liver abscess in the gerbil (Meriones unguiculatus). Am J Pathol 117:71-80 (Pubitemid 15200368)
8. Giri RK, Das BR (1996) Differential expression of c-jun and c-myc in N-nitroso diethylamine-induced hepatic oncogenesis in AKR mice. Cancer Lett 109:121-127 (Pubitemid 27026212)
9. Wise M, Bialek S, Finelli L, Bell BP, Sorvillo F (2008) Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology 47:1128-1135 (Pubitemid 351547899)
10. El-Serag HB, Hampel H, Javadi F (2006) The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 4:369-380 (Pubitemid 43343895)
11. El-Serag HB, Tran T, Everhart JE (2004) Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126:460-468 (Pubitemid 38182303)
12. Cui J, Holmes EH, Greene TG, Liu PK (2000) Oxidative DNA damage precedes DNA fragmentation after experimental stroke in rat brain. FASEB J 14:955-967 (Pubitemid 30241673)
13. Valyi-Nagy T, Dermody TS (2005) Role of oxidative damage in the pathogenesis of viral infections of the nervous system. Histol Histopathol 20:957-967 (Pubitemid 40932613)
14. Cotler SJ, Kallwitz E, Tencate V, Bhushan A, Berkes J, Benedetti E, Layden-Almer J, Layden TJ, Valyi-Nagy T, Guzman G (2007) Diabetes and hepatic oxidative damage are associated with hepatitis C progression after liver transplantation. Transplantation 84:587-591 (Pubitemid 47429038)
15. Everhart JE, Wei Y, Eng H, Charlton MR, Persing DH, Wiesner RH, Lake JR, Germer JJ, Zetterman RK, Hoofnagle JH (1999) Recurrent and new hepatitis C virus infection after liver transplantation. Hepatology 29:1220-1226 (Pubitemid 29168758)
16. Lefkowitch JH (2009) Recent developments in liver pathology. Hum Pathol 40:445-455
17. Batts KP, Ludwig J (1995) Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19:1409-1417
18. Demetris AJ, Adeyi O, Bellamy CO, Clouston A, Charlotte F, Czaja A, Daskal I, El-Monayeri MS, Fontes P, Fung J, Gridelli B, Guido M, Haga H, Hart J, Honsova E, Hubscher S, Itoh T, Jhala N, Jungmann P, Khettry U, Lassman C, Ligato S, Lunz JG 3rd, Marcos A, Minervini MI, Molne J, Nalesnik M, Nasser I, Neil D, Ochoa E, Pappo O, Randhawa P, Reinholt FP, Ruiz P, Sebagh M, Spada M, Sonzogni A, Tsamandas AC, Wernerson A, Wu T, Yilmaz F (2006) Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 44:489-501 (Pubitemid 44214890)
19. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313-1321 (Pubitemid 40770284)
20. Anthony PP, Vogel CL, Barker LF (1973) Liver cell dysplasia: a premalignant condition. J Clin Pathol 26:217-223
21. Anthony PP (1976) Precursor lesions for liver cancer in humans. Cancer Res 36:2579-2583
22. Guzman G, Wu SJ, Kajdacsy-Balla A, Cotler SJ (2006) Alphamethylacyl-CoA racemase (AMACR/P504S) can distinguish hepatocellular carcinoma and dysplastic hepatocytes from benign nondysplastic hepatocytes. Appl Immunohistochem Mol Morphol 14:411-416 (Pubitemid 44813701)
23. Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ, Trent JM, Isaacs WB, De Marzo AM (2002) Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res 62:2220-2226 (Pubitemid 34411693)
24. Jiang Z, Wu CL, Woda BA, Iczkowski KA, Chu PG, Tretiakova MS, Young RH, Weiss LM, Blute RD Jr, Brendler CB, Krausz T, Xu JC, Rock KL, Amin MB, Yang XJ (2004) Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. Histopathology 45:218-225 (Pubitemid 39294698)
25. Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349:825-832 (Pubitemid 27129209)
26. Russack V, Vass L, Gupta PK (1993) Comparison of morphologic features of benign hepatocytes associated with nonmalignant and malignant liver lesions. Acta Cytol 37:153-157 (Pubitemid 23109647)
27. Gong G, Waris G, Tanveer R, Siddiqui A (2001) Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci USA 98:9599-9604 (Pubitemid 32769349)
28. Abdalla MY, Ahmad IM, Spitz DR, Schmidt WN, Britigan BE (2005) Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses. J Med Virol 76:489-497 (Pubitemid 40943258)
29. Evans JL, Maddux BA, Goldfine ID (2005) The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 7:1040-1052 (Pubitemid 40967154)
30. Poli G (2000) Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 21:49-98 (Pubitemid 30642764)
31. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB (2005) Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 54:533-539 (Pubitemid 40403031)
32. Campbell JS, Johnson MM, Bauer RL, Hudkins KL, Gilbertson DG, Riehle KJ, Yeh MM, Alpers CE, Fausto N (2007) Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis. Differentiation 75:843-852 (Pubitemid 350086173)